MARKERS OF EXTRACELLULAR MATRIX TURNOVER AND RISK OF DEATH IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS FROM I-PRESERVE

被引：2
作者：
Chow, Sheryl L. [1 ]
Krum, Henry [1 ]
O'Barr, Stephen A. [1 ]
Zile, Michael [1 ]
Carson, Peter [1 ]
Komajda, Michel [1 ]
McMurray, John [1 ]
Anand, Inderjit [1 ]
机构：
[1] Western Univ Hlth Sci, Pomona, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60969-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1216-192
引用
收藏
页码：A969 / A969
页数：1
相关论文
共 50 条
  • [41] Prognostic value of baseline NT-proBNP and its interactions with irbesartan treatment in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial
    Anand, I. S.
    Rector, T. S.
    Cleland, J. G.
    Kckelvie, R. S.
    Persson, H.
    Mcmurray, J. J.
    Zile, M.
    Komajda, M.
    Massie, B.
    Carson, P.
    EUROPEAN HEART JOURNAL, 2011, 32 : 495 - 495
  • [42] Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction
    Albar, Zainab
    Albakri, Marwah
    Hajjari, Jamal
    Karnib, Mohamad
    Janus, Scott E.
    Al-Kindi, Sadeer G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 167 : 68 - 75
  • [43] Cardiovascular risk and death in patients with rheumatic diseases and heart failure with preserved ejection fraction
    Breunig, M.
    Morbach, C.
    Kleinert, S.
    Tony, H. P.
    Angermann, C. E.
    Stoerk, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1117 - 1117
  • [44] The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
    Franssen, C.
    Gonzalez Miqueo, A.
    NETHERLANDS HEART JOURNAL, 2016, 24 (04) : 259 - 267
  • [45] The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
    C. Franssen
    A. González Miqueo
    Netherlands Heart Journal, 2016, 24 : 259 - 267
  • [46] Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial
    Rector, Thomas S.
    Carson, Peter E.
    Anand, Inder S.
    McMurray, John J.
    Zile, Michael R.
    McKelvie, Robert S.
    Komajda, Michel
    Kuskowski, Michael
    Massie, Barry M.
    CIRCULATION-HEART FAILURE, 2012, 5 (02) : 217 - 225
  • [47] Malnutrition Risk In Patients With Heart Failure With Preserved Ejection Fraction
    Beleh, Noha M.
    Garg, Noemi
    Humphrey, Lauren
    Melendez, Tori L.
    Pan, Michael
    Konerman, Matthew C.
    Hummel, Soctt L.
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S54 - S54
  • [48] Sudden Cardiac Death in Heart Failure Patients With Preserved Ejection Fraction
    Adabag, Selcuk
    Smith, Lindsay G.
    Anand, Inder S.
    Berger, Alan K.
    Luepker, Russell V.
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : 749 - 754
  • [49] Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
    Schrutka, Lore
    Seirer, Benjamin
    Rettl, Rene
    Dachs, Theresa-Marie
    Binder, Christina
    Duca, Franz
    Dalos, Daniel
    Badr-Eslam, Roza
    Kastner, Johannes
    Hengstenberg, Christian
    Frommlet, Florian
    Bonderman, Diana
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [50] Mode of Death in Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Patel, Ravi B.
    Michel, Alexander
    Shah, Sanjiv J.
    Senni, Michele
    Gheorghiade, Mihai
    Butler, Javed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (05) : 556 - 569
12345